CyanoCapture

📍 Oxford, United Kingdom🗓 Founded 2021👥 17 employees💰 Last funded Oct 2024
Biotechnology🌐 cyanocapture.com
Website LinkedIn
Around 27% of essential drugs on the FDA list are categorised as at risk due to uncertain supply chains. CyanoCapture is an advanced Synthetic Biology company that is leveraging the worlds fastest carbon-negative cell to synthesise drug precursor molecules at lower cost and address this problem. Winner - Elon Musk XPRIZE 2021 Winner - Shell New Energy Challenge 2022 Winner - Horizon Europe 2024 Winner - LOreal GSI x Hello Tomorrow 2024 Enquiries: Partnerships@cyanocapture.com Licensing@cyanocapture.com
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
2
Hong Kong
1
Investor activity2023–2024 · investors recorded per year
2023220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in CyanoCapture?
CyanoCapture has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did CyanoCapture last raise funding?
The most recent investment in CyanoCapture recorded on gritt.io was in October 2024.
When was CyanoCapture founded?
CyanoCapture was founded in 2021.
What industry is CyanoCapture in?
CyanoCapture operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is CyanoCapture based?
CyanoCapture is headquartered in Oxford, United Kingdom.